132 related articles for article (PubMed ID: 24358217)
1. Alternative splicing events is not a key event for gene expression regulation in uremia.
Sallée M; Fontès M; Louis L; Cérini C; Brunet P; Burtey S
PLoS One; 2013; 8(12):e82702. PubMed ID: 24358217
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
[TBL] [Abstract][Full Text] [Related]
3. Human-Specific Abnormal Alternative Splicing of Wild-Type
Lea WA; Parnell SC; Wallace DP; Calvet JP; Zelenchuk LV; Alvarez NS; Ward CJ
J Am Soc Nephrol; 2018 Oct; 29(10):2482-2492. PubMed ID: 30185468
[TBL] [Abstract][Full Text] [Related]
4. Alternative Splicing in CKD.
Stevens M; Oltean S
J Am Soc Nephrol; 2016 Jun; 27(6):1596-603. PubMed ID: 26763787
[TBL] [Abstract][Full Text] [Related]
5. [Identification of a novel splicing mutation of PKD1 gene in a pedigree affected with autosomal dominant polycystic kidney disease].
Xu P; Zou Y; Li J; Huang S; Gao M; Kang R; Gao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):778-781. PubMed ID: 27984604
[TBL] [Abstract][Full Text] [Related]
6. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
[TBL] [Abstract][Full Text] [Related]
7. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.
Claverie-Martin F; Gonzalez-Paredes FJ; Ramos-Trujillo E
RNA Biol; 2015; 12(4):369-74. PubMed ID: 25757501
[TBL] [Abstract][Full Text] [Related]
8. Unproductive alternative splicing and nonsense mRNAs: a widespread phenomenon among plant circadian clock genes.
Filichkin SA; Mockler TC
Biol Direct; 2012 Jul; 7():20. PubMed ID: 22747664
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of alternative splicing and functionality in neuronal differentiation of P19 cells.
Suzuki H; Osaki K; Sano K; Alam AH; Nakamura Y; Ishigaki Y; Kawahara K; Tsukahara T
PLoS One; 2011 Feb; 6(2):e16880. PubMed ID: 21365003
[TBL] [Abstract][Full Text] [Related]
10. Three exonic mutations in polycystic kidney disease-2 gene (PKD2) alter splicing of its pre-mRNA in a minigene system.
Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
Gene; 2016 Mar; 578(1):117-23. PubMed ID: 26692149
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
12. Novel splicing and missense mutations in autosomal dominant polycystic kidney disease 1 (PKD1) gene: expression of mutated genes.
Aguiari G; Savelli S; Garbo M; Bozza A; Augello G; Penolazzi L; De Paoli Vitali E; La Torre C; Cappelli G; Piva R; del Senno L
Hum Mutat; 2000 Nov; 16(5):444-5. PubMed ID: 11058904
[TBL] [Abstract][Full Text] [Related]
13. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease.
Tan YC; Blumenfeld J; Michaeel A; Donahue S; Balina M; Parker T; Levine D; Rennert H
Clin Genet; 2011 Sep; 80(3):287-92. PubMed ID: 20950398
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression and splicing of the rat polycystic kidney disease 1 gene.
Xu H; Shen J; Walker CL; Kleymenova E
DNA Seq; 2001 Dec; 12(5-6):361-6. PubMed ID: 11913782
[TBL] [Abstract][Full Text] [Related]
15. Exome-Based Rare-Variant Analyses in CKD.
Cameron-Christie S; Wolock CJ; Groopman E; Petrovski S; Kamalakaran S; Povysil G; Vitsios D; Zhang M; Fleckner J; March RE; Gelfman S; Marasa M; Li Y; Sanna-Cherchi S; Kiryluk K; Allen AS; Fellström BC; Haefliger C; Platt A; Goldstein DB; Gharavi AG
J Am Soc Nephrol; 2019 Jun; 30(6):1109-1122. PubMed ID: 31085678
[TBL] [Abstract][Full Text] [Related]
16. Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma.
Li R; Ochs MF; Ahn SM; Hennessey P; Tan M; Soudry E; Gaykalova DA; Uemura M; Brait M; Shao C; Westra W; Bishop J; Fertig EJ; Califano JA
PLoS One; 2014; 9(3):e91263. PubMed ID: 24675808
[TBL] [Abstract][Full Text] [Related]
17. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
[TBL] [Abstract][Full Text] [Related]
18. Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
Kocyigit I; Ozturk F; Eroglu E; Karaca Z; Kaynar AS; Cetin M; Tokgoz B; Sipahioglu MH; Bayramov R; Sen A; Oymak O; Ecder T; Axelsson J
Clin Exp Nephrol; 2019 Sep; 23(9):1130-1140. PubMed ID: 31134465
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of autosomal dominant polycystic kidney disease type 1 and hereditary renal hypouricemia type 2: A model of early-onset and fast cyst progression.
Peces R; Mena R; Peces C; Cuesta E; Selgas R; Barruz P; Lapunzina P; Nevado J
Clin Genet; 2020 Jun; 97(6):857-868. PubMed ID: 32166738
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder.
Kim KI; Jeong S; Han N; Oh JM; Oh KH; Kim IW
Front Med; 2017 Sep; 11(3):378-385. PubMed ID: 28623542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
